• Explore /
  • Poster
  • / A phase 2 study of pamiparib in the treatment of patients with locally advanced or metastatic HER2-negative breast cancer with germline <em>BRCA</em> mutation.

A phase 2 study of pamiparib in the treatment of patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutation.

Abstract Video & Slides Poster

Authors

null

Tao Sun

Liaoning Cancer Hospital & Institute, Shenyang, China

Tao Sun , Yanxia Shi , Jiuwei Cui , Yongmei Yin , Quchang Ouyang , Qiang Liu , Qingyuan Zhang , Yiding Chen , Shao Zhimin , Shouman Wang , Xiaojia Wang , Zhongsheng Tong , Yahua Zhong , Min Yan , Xi Yan , Chuan Wang , Haiyuan Yang , Miao Li , Xiao Xiang , Binghe Xu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Metastatic

Track

Breast Cancer

Sub Track

Other Breast Cancer Subtypes

Clinical Trial Registration Number

NCT03575065

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 1087)

DOI

10.1200/JCO.2021.39.15_suppl.1087

Abstract #

1087

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Ian E. Krop

First Author: Severine Guiu Lahaye

First Author: Chuanliang Cui

First Author: Wang Qu